Zacks Research Weighs in on Danaher's Q2 Earnings (NYSE:DHR)

Danaher Co. (NYSE:DHR - Free Report) - Stock analysts at Zacks Research cut their Q2 2025 earnings estimates for Danaher in a research note issued to investors on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the conglomerate will post earnings of $1.77 per share for the quarter, down from their prior estimate of $1.85. The consensus estimate for Danaher's current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher's Q3 2025 earnings at $1.86 EPS, FY2025 earnings at $7.62 EPS, Q1 2026 earnings at $1.86 EPS, Q2 2026 earnings at $2.05 EPS, Q3 2026 earnings at $2.06 EPS, Q4 2026 earnings at $2.54 EPS, FY2026 earnings at $8.51 EPS and FY2027 earnings at $9.43 EPS.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts' consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the company earned $2.09 EPS.

Several other analysts also recently issued reports on DHR. Scotiabank began coverage on shares of Danaher in a report on Monday, December 23rd. They issued a "sector perform" rating and a $265.00 price target on the stock. Guggenheim began coverage on shares of Danaher in a report on Thursday, December 19th. They issued a "buy" rating and a $275.00 price target on the stock. Wells Fargo & Company reduced their price objective on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Thursday, January 30th. StockNews.com lowered shares of Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, December 14th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Danaher from $310.00 to $300.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $278.00.

Danaher Price Performance

Shares of NYSE DHR traded up $1.91 on Friday, hitting $209.86. The company's stock had a trading volume of 6,209,935 shares, compared to its average volume of 5,372,101. Danaher has a 12-month low of $196.80 and a 12-month high of $281.70. The company has a market capitalization of $151.58 billion, a price-to-earnings ratio of 39.75, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a 50 day moving average of $226.71 and a 200-day moving average of $247.11.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.32 dividend. This is an increase from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. Danaher's dividend payout ratio (DPR) is presently 20.45%.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 11.10% of the company's stock.

Institutional Trading of Danaher

A number of large investors have recently modified their holdings of DHR. Heck Capital Advisors LLC acquired a new position in Danaher during the 4th quarter valued at about $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter valued at about $31,000. Golden State Wealth Management LLC acquired a new position in Danaher during the 4th quarter valued at about $31,000. Teachers Insurance & Annuity Association of America acquired a new position in Danaher during the 3rd quarter valued at about $39,000. Finally, Hurley Capital LLC acquired a new position in shares of Danaher in the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.